Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 7340E12A-2AE5-11E3-A4E0-796A10BDE39D cql: author exact 0D3B56D0-0947-11E4-AA83-18CA4B2F559A

Add to list
- Journal Article
- A1
- open access
Building a human physiologically based pharmacokinetic model for aflatoxin B1 to simulate interactions with drugs

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Jia Ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and An Vermeulen (UGent)

(2023) PHARMACEUTICS. 15(3).
Add to list
Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Jia Ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and An Vermeulen (UGent)

(2023) World Mycotoxin Forum, 14th Conference, Abstracts.
Add to list
Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , An Vermeulen (UGent) , Jia Ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) and Sarah De Saeger (UGent)

(2023) Population Approach Group Europe (PAGE), 31st Annual Conference 2023, Abstracts.
Add to list
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz an aflatoxin B1 : an approach to unravel possible interactions

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and Marthe De Boevre (UGent)

(2022) Research Day 2022, Abstracts.
Add to list
- Journal Article
- A1
- open access
Unravelling the pharmacokinetics of aflatoxin B1 : in vitro determination of Michaelis-Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Sarah De Saeger (UGent)

(2022) FRONTIERS IN MICROBIOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Possible mechanisms of the interplay between drugs and mycotoxins : is there a possible impact?

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Siska Croubels (UGent) , Sarah De Saeger (UGent) , Jan Van Bocxlaer (UGent) and Marthe De Boevre (UGent)

(2022) TOXINS. 14(12).
Add to list
- Conference Paper
- C3
- open access
Mycotoxin-drug interactions at the level of CYP450 enzymes

Orphélie Lootens (UGent) , Sarah De Saeger (UGent) , Marthe De Boevre (UGent) , An Vermeulen (UGent) and Jan Van Bocxlaer (UGent)

(2021) Research Day 2021, Abstracts.
Add to list
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz and aflatoxin B1 : an approach to unravel possible interactions

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and Marthe De Boevre (UGent)

(2021) Mycotoxin Workshop, 42nd, Abstracts.

Academic Bibliography

Building a human physiologically based pharmacokinetic model for aflatoxin B1 to simulate interactions with drugs

Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant

Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant

Determination of pharmacokinetic parameters of efavirenz an aflatoxin B1 : an approach to unravel possible interactions

Unravelling the pharmacokinetics of aflatoxin B1 : in vitro determination of Michaelis-Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes

Possible mechanisms of the interplay between drugs and mycotoxins : is there a possible impact?

Mycotoxin-drug interactions at the level of CYP450 enzymes

Determination of pharmacokinetic parameters of efavirenz and aflatoxin B1 : an approach to unravel possible interactions

Contents

Support

Contact